Search details
1.
Cost-effectiveness of poly-(ADP-ribose) polymerase (PARP)-inhibitors for the maintenance treatment after responding to first- and second-line chemotherapy in advanced ovarian cancer.
J Oncol Pharm Pract
; 29(2): 457-464, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36344039
2.
The screening with the liquid biopsy for the rechallenge with anti-epidermal growth factor receptor antibodies in metastatic colorectal cancer A perspective based on pharmacological costs.
Recenti Prog Med
; 114(9): 563-564, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37530025
Results
1 -
2
de 2
1
Next >
>>